The DOI matches its Crossref record; 248 of the 248 references it cites were found in a registry or an index.
The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
Open accessAbstract
Gut microbiota is emerging as a key regulator of many disease conditions and its dysregulation is implicated in the pathogenesis of several gastrointestinal and extraintestinal disorders. More recently, gut microbiome alterations have been linked to neurodegeneration through the increasingly defined gut microbiota brain axis, opening the possibility for new microbiota-based therapeutic options. Although several studies have been conducted to unravel the possible relationship between Alzheimer’s Disease (AD) pathogenesis and progression, the diagnostic and therapeutic potential of approaches aiming at restoring gut microbiota eubiosis remain to be fully addressed. In this narrative review, we briefly summarize the role of gut microbiota homeostasis in brain health and disease, and we present evidence for its dysregulation in AD patients. Based on these observations, we then discuss how dysbiosis might be exploited as a new diagnostic tool in early and advanced disease stages, and we examine the potential of prebiotics, probiotics, fecal microbiota transplantation, and diets as complementary therapeutic interventions on disease pathogenesis and progression, thus offering new insights into the diagnosis and treatment of this devastating and progressive disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Following the successful use of FMT in the treatment of refractory or recurrent Clostridium difficile infection, several studies have been conducted to explore FMT as a therapeutic strategy for a wide range of neurological disorders, including multiple sclerosis, epilepsy, ASD, Tourette syndrome, diabetic neuropathy, AD and PD, with promising preclinical and clinical data [30,465,466,467,468].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [30]
Experimental — accuracy not yet measuredIn the citing paper
“GM-based biomarkers have recently been considered as promising early and prodromal diagnostic tools in various neurological diseases, such as multiple sclerosis, AD and PD itself [30,156,157]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888 · cited 1×
“• Through incoming and outgoing branches of the vagus nerve [26], which represents the major modulatory pathway [27].”
BackgroundParada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00277 · Cited by 3,820 · cited 1×
“As mentioned, another beneficial role exerted by the gut microbiota is the production of SCFAs, including butyrate, propionate, and acetate, essential for energy production, gut epithelia homeostasis, and immune regulation [83].”
BackgroundFormation of short chain fatty acids by the gut microbiota and their impact on human metabolism
Morrison, D. J., & Preston, T. (2016) · Gut Microbes · doi:10.1080/19490976.2015.1134082 · Cited by 3,781
Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019) · Microorganisms · doi:10.3390/microorganisms7010014 · Cited by 3,462 · cited 1×
“Although the composition of a “healthy microbiota” has not yet been defined, a balanced environment between the host and microorganisms is known to be essential to carry on the necessary immunological and metabolic functions [58].”
BackgroundPathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
Normal gut microbiota modulates brain development and behavior
Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., Hibberd, M. L., Forssberg, H., & Pettersson, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010529108 · Cited by 3,228 · cited 1×
“This alteration, in turn, may affect the CNS through the modulation of stress hormones [28].”
Background
Research works printed but not linked: 1
- Rasmussen, 2019, Alzheimer’s Disease—Why We Need Early Diagnosis, Degener. Neurol. Neuromuscul. Dis., 9, 123
Cited by
Communication of gut microbiota and brain via immune and neuroendocrine signaling
Kasarello, K., Cudnoch-Jedrzejewska, A., & Czarzasta, K. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1118529 · Cited by 247
“Moreover, numerous studies indicate a wellchosen diet as a quick way to modify the composition and metabolism of the gut microbiota, reduce inflammation, and help maintain eubiosis and proper dependencies in the gut-brain axis (Metta et al., 2022; Varesi et al., 2022).”
BackgroundResultUpdates in Alzheimer's disease: from basic research to diagnosis and therapies
Liu, E., Zhang, Y., & Wang, J.-Z. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00432-x · Cited by 199
“The human gut harbors bacteria, viruses, and fungi [138].”
BackgroundAn Explainable AI Paradigm for Alzheimer’s Diagnosis Using Deep Transfer Learning
Mahmud, T., Barua, K., Habiba, S. U., Sharmen, N., Hossain, M. S., & Andersson, K. (2024) · Diagnostics · doi:10.3390/diagnostics14030345 · Cited by 167
“For feature extraction, by leveraging its ability to capture high-level features from input images, such as edges, textures, and shapes, we used EfficientNet as a feature extractor [1], where we realized a 6400 × 1280 feature matrix [33].”
MethodBlood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Varesi, A., Carrara, A., Pires, V. G., Floris, V., Pierella, E., Savioli, G., Prasad, S., Esposito, C., Ricevuti, G., Chirumbolo, S., et al. (2022) · Cells · doi:10.3390/cells11081367 · Cited by 164
“Though data are still inconclusive, gut bacteria family and genus shifts might represent promising tools as novel biomarkers for the diagnosis and progression of AD, and the restoration of gut microbiota balance a potential therapeutic approach [380].”
BackgroundSelf-citationBicknell, B. T., Liebert, A. D., Borody, T. J., Herkes, G., McLachlan, C. S., & Kiat, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119577 · Cited by 146
“There is also some evidence that MCI and early-stage AD already show signs of pro-inflammatory bacteria increases, such as Escherichia/Shigella , in addition to increased inflammation [68].”
Metadata
- Authors
- Varesi, A., Pierella, E., Romeo, M., Piccini, G. B., Alfano, C., Bjørklund, G., Oppong, A., Ricevuti, G., Esposito, C., Chirumbolo, S., & Pascale, A.
- Affiliations
- University of Pavia (IT)
- University of Lancashire (GB)
- Université Libre de Bruxelles (BE)
- Policlinico San Matteo Fondazione (IT)
- Council for Nutritional and Environmental Medicine (NO)
- University of Verona (IT)
- Corresponding author
- Varesi, Angelica
- Ricevuti, Giovanni
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2022-02-05
- Volume
- 14
- Issue
- 3
- Pages
- 668
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC8840394
- OpenAlex
- W4210475085
- Cited by
- 225
- References
- 248
- Citations by year
- 2026: 24 · 2025: 54 · 2024: 68 · 2023: 53 · 2022: 26
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CLOK (University of Central Lancashire) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IrInSubria (University of Insubria) (submittedVersion, other-oa)
- Funders
- Università degli Studi di Pavia
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- gut microbiota, Alzheimer's disease, gut-brain axis, dysbiosis, neurodegeneration, microbiota-based therapy, prebiotics, probiotics, fecal microbiota transplantation, diet, early diagnosis, disease progression
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Alzheimer Disease, Humans, Prebiotics, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment. https://app.cochat.ai/papers/10.3390/nu14030668
- The paper
- Varesi, A., Pierella, E., Romeo, M., Piccini, G. B., Alfano, C., Bjørklund, G., Oppong, A., Ricevuti, G., Esposito, C., Chirumbolo, S., & Pascale, A. (2022). The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment. Nutrients. https://doi.org/10.3390/nu14030668
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.